Please assess the completion status of the following clinical trial:

Trial Title: Outcome Impact of Different Tranexamic Acid Regimen in Cardiac Surgery With Cardiopulmonary Bypass

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~1. Male or female adult patients aged 18\~70 years.~2. Patients receiving cardiac surgery with cardiopulmonary bypass~3. Written Informed consent obtained~Exclusion Criteria:~1. Acquired chromatic disorder~2. Active intravascular coagulation~3. Previous convulsion or seizure~4. Allergy or contraindication to tranexamic acid injection or its components~5. Feeding or pregnancy women~6. Terminal illness with a life expectancy of less than 3 months~7. Patients with mental or legal disability~8. Currently enrolled in another perioperative interventional study

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 70 Years
- Healthy Volunteers: f

Study Arms:
- Tranexamic Acid Dosage 1 (Type: EXPERIMENTAL): A bolus of 30 mg/kg Tranexamic Acid for 20 min followed by a maintenance dose of 16 mg/kg/h Tranexamic Acid until the end of surgery, and a pump prime dose 2 mg/kg.
- Tranexamic Acid Dosage 2 (Type: ACTIVE_COMPARATOR): A bolus of 10 mg/kg Tranexamic Acid for 20 min followed by a maintenance dose of 2 mg/kg/h Tranexamic Acid until the end of surgery, and a pump prime dose 1 mg/kg.

Based on this trial design, predict the completion outcome and termination type (if applicable).